“Our team really enjoyed working with ibiologix over the past year. ibiologix gains our full confidence and trust in their non-clinical development services. They perfectly complemented our internal project team and as a small Biotech company gave us the bandwidth we needed to pursue multiple projects in parallel.”

Head of Non-Clinical Development at Silence Therapeutics

“iBiologix provided us with the non-clinical development support we needed to help advance our lead ADC, NBE-002, into clinical development.  The iBiologix team (Sebastian & Simon), integrated well into the NBE team supporting NBE-002 and continue to support us as we progress with NBE-002 in the clinic.  We can highly recommend iBiologix and continue to enjoy working with them.”

CSO at NBE Therapeutics

“iBiologix provided excellent support during the development of our biotherapeutics, particularly helping with the safety and immunogenicity risk assessment for regulatory submission and the development of clinical assays. Knowledgeable, responsive and excellent to work with. The team added significant value to our program and we are very happy to recommend iBiologix to any company developing complex protein therapeutics.”

Rinat Tabakman, PhD VP Development at KAHR